Episode 10: How Biosimilars Could Impact the Future of Cancer Care

Rowena Schwartz, PharmD, BCOP, associate professor of pharmacy at the University of Cincinnati, joins Deborah Struth, MSN, RN, ONS research associate, to discuss the rapid emergence of biosimilar products on the market and how they’ll impact the treatment of cancer. Learn more about what biosimilars are, their approval processes, and the important things to know for practice.  Music Credit: "Fireflies and Stardust" Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 3.0 License http://creativecommons.org/licenses/by/3.0   Episode Notes: Biosimilars Offer New Options for Treatment and New Concepts for Patient Education Biosimilars: Considerations for Oncology Nurses S. Food and Drug Administration – Biosimilars American Society of Clinical Oncology Statement: Biosimilars in Oncology Chemotherapy, Biotherapy, and Hormonal Therapy Resources